HPV-Positive Oropharyngeal Cancer The nurse's role in patient management of treatment-related sequclae

被引:0
|
作者
Cerar, Jennifer [1 ]
Bryant, Katherine B. [2 ]
Shoemaker, Scarlett E. [2 ]
Battiato, Linda [2 ]
Wood, Gloria [3 ]
机构
[1] Moffit Canc Ctr, Tampa, FL 33612 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
HPV-positive oropharyngeal cancer; self-care; survivorship care and Late effects; SQUAMOUS-CELL CARCINOMA; QUALITY-OF-LIFE; NECK-CANCER; HUMAN-PAPILLOMAVIRUS; HEAD; SURVIVORSHIP; IMPACT; HYPOTHYROIDISM; RADIOTHERAPY; SURVIVAL;
D O I
10.1188/20.CJON.153-159
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Patients diagnosed with orophayngeal cancer IOPC) make up about 3% of all new cancer cases in the United States, with increasing numbers of these patients being diagnosed aged youngei than 45 yeais and with human papillomavirus (HPV)-positive disease. Treatment effects may alter patients physical and mental states during and after treatment. OBJECTIVES:lhis article provides an overview of possible OPC treatment long-term effects to equip oncology nurses with information needed to empowei patients with OPC to perform self-caie. METHODS: The OPC literature was reviewed to identify incidence, survival, risk factors, symptoms, treatment options, and treatment effects. FINDINGS: This aiticle piovides a foundation for the plan of care for patients with OPC and strategies tor patients to contribute to their self-care.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 50 条
  • [31] Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation
    Samuels, Stuart E.
    Tao, Yebin
    Lyden, Teresa
    Haxer, Marc
    Spector, Matthew
    Malloy, Kelly M.
    Prince, Mark E.
    Bradford, Carol R.
    Worden, Francis P.
    Schipper, Matthew
    Eisbruch, Avraham
    ORAL ONCOLOGY, 2016, 54 : 68 - 74
  • [32] 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes
    Chen, Stephanie Y.
    Last, Aisling
    Ettyreddy, Abhinav
    Kallogjeri, Dorina
    Wahle, Benjamin
    Chidambaram, Smrithi
    Mazul, Angela
    Thorstad, Wade
    Jackson, Ryan S.
    Zevallos, Jose P.
    Pipkorn, Patrik
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 42 (03)
  • [33] Radiation-induced parotid changes in oropharyngeal cancer patients: the role of early functional imaging and patient -/treatment-related factors
    Marzi, Simona
    Farneti, Alessia
    Vidiri, Antonello
    Di Giuliano, Francesca
    Marucci, Laura
    Spasiano, Filomena
    Terrenato, Irene
    Sanguineti, Giuseppe
    RADIATION ONCOLOGY, 2018, 13
  • [34] Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis
    Bossi, P.
    Orlandi, E.
    Miceli, R.
    Perrone, F.
    Guzzo, M.
    Mariani, L.
    Granata, R.
    Locati, L.
    Fallai, C.
    Cortelazzi, B.
    Pilotti, S.
    Scaramellini, G.
    Gloghini, A.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 694 - 699
  • [35] Prognostic significance of cystic nodal metastasis in HPV-positive oropharyngeal cancer
    Pupic-Bakrac, Jure
    Rasic, Mario
    ENT-EAR NOSE & THROAT JOURNAL, 2022,
  • [36] Dental health in patients with and without HPV-positive oropharyngeal and tongue cancer
    Jouhi, Lauri
    Sikio, Jenna
    Suomalainen, Anni
    Mroueh, Rayan
    Makitie, Antti
    Meurman, Jukka H.
    PLOS ONE, 2022, 17 (09):
  • [37] Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer
    Rutkowski, Tomasz W.
    Mazurek, Agnieszka M.
    snietura, Miroslaw
    Hejduk, Beata
    Jedrzejewska, Maja
    Bobek-Billewicz, Barbara
    d'Amico, Andrea
    Piglowski, Wojciech
    Wygoda, Andrzej
    Skladowski, Krzysztof
    Kolosza, Zofia
    Widlak, Piotr
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [38] Advances in the Management of HPV-Related Oropharyngeal Cancer
    De Felice, F.
    Tombolini, V.
    Valentini, V.
    de Vincentiis, M.
    Mezi, S.
    Brugnoletti, O.
    Polimeni, A.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [39] De-escalated Management of HPV-positive Oropharyngeal Carcinoma: Improving Outcomes with Personalized Approaches
    Yacoub, Irini
    Shamseddine, Achraf
    Qian, Joshua
    Youssef, Mary
    Safavi, Amir H.
    Lee, Nancy Y.
    SEMINARS IN RADIATION ONCOLOGY, 2025, 35 (02) : 157 - 165
  • [40] New treatment strategies for HPV-positive head and neck cancer
    Kofler, B.
    Laban, S.
    Busch, C. J.
    Loerincz, B.
    Knecht, R.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (07) : 1861 - 1867